glp-1 patches brands Patches: What They Are and What You Should Know GLP-1 Companion System
Description
While cardiovascular outcome data for retatrutide is still accumulating, the prudent approach for anyone with active cardiovascular disease is to remain on compounds with established cardiovascular safety profiles

10.2337/diacare.28.5.1092 30 DeYoungM

The results for orforglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, show less dramatic weight loss than injectable medications but are still clinically meaningful, according to the manufacturer Eli Lilly
Daily Dosing: Comparing Convenience and Compliance FDA-Approved Oral Tablets: Must be taken first thing in the morning on an empty stomach Take with only 4 ounces of water or less Wait 30 minutes before eating, drinking anything else, or taking other medications Timing and fasting window are critical for absorption Requires daily compliance Compounded ODT Formulations: Dissolve under the tongue or in the cheek Taken once daily Generally no food/water restrictions (though specific instructions vary) May be more convenient than swallowed tablets Still requires daily compliance Injectable GLP-1s: Administered once weekly at any time of day Can be taken with or without food No fasting period required More forgiving if you're slightly late with your dose Studies show that patient preferences often shift once they understand these requirements

many patients with CKD go unrecognized